NYSE:LIT 9 February 2026

June 20, 2026, 1:51 PM EDT. CME Group's shares fell 8.6% last week and 14.8% over the past month, prompting renewed questions on its valuation at around $246 per share. The stock shows a 6.6% decline over the past year, lagging behind peers despite a strong 54.2% three-year gain. Using an Excess Returns model, analysts estimate CME's intrinsic value at $250.47, suggesting the stock is fairly valued with a slight 1.6% undervaluation. This model calculates profitability above shareholder required returns through book value and earnings per share projections. Market sentiment is affected by shifts in trading volumes and investor positioning in derivatives, crucial in capital markets. CME's price-to-earnings ratio also offers insight, balancing price paid against company earnings.